TWST
Twist Bioscience Corp
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$166.99
+7.35%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 21.25x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 24.84x
- Price / sales
- 25.64x
- Price / cash flow
- -208.62x
Enterprise value
- Enterprise value
- $11.0B
- EV / sales
- 25.47x
- EV / EBITDA
- -102.04x
- EV / EBIT
- -79.83x
- Market cap
- $11.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026